The best semaglutide dose for weight loss varies according to your starting weight, risks, and stage of treatment. Read to ...

Eli Lilly and Company’s LLY shares declined 13.5% in the past three months. Though demand for its popular tirzepatide drugs, ...

It leaves an image of Europe as a corporate has-been. Are the continent’s companies really that bad? Here are some counterpoints: America’s S&P 500 is in the midst of an artificial intelligence-led ...

In this review, we go over what HealthyWage is, how it works, and how you get paid. If your health is a focus this year, this ...

With new treatments in neurology, and more in development in cardiology and autoimmune diseases, precision medicine is moving ...

The round is one of Europe’s largest-ever biotech VC deals, signalling investor appetite for the booming weight loss market.

Startup Virta Health saw 60% revenue growth last year, topping $100 million, driven by demand for its employer weight loss ...

A combination image shows an injection pen of Zepbound, Eli Lilly’s weight loss drug, and boxes of Wegovy, manufactured by Novo Nordisk. Reuters Eli Lilly said Wednesday that its obesity drug Zepbound ...

FOIA requests to the federal government often are signals. They can be an important early warning of bad publicity, litigation to come, or uncertainties to be hedged and gamed out. When the flow of ...

AS HOLIDAY TREATS GIVE WAY TO NEW YEAR’S RESOLUTIONS, the names of GLP-1 weight-loss drugs like Ozempic and Wegovy will be on millions of lips this January—in addition to any leftover fruitcake, ...

Comparing Tyrzepatide and Semaglutide in the slimming drug market, with potential growth driven by increasing obesity rates worldwide. Explore more here.